Journal article

Essential requirement for beta-arrestin2 in mouse intestinal tumors with elevated Wnt signaling

Caroline Bonnans, Maud Flaceliere, Fanny Grillet, Christelle Dantec, Jean-Pierre Desvignes, Julie Pannequin, Dany Severac, Emeric Dubois, Frederic Bibeau, Virginie Escriou, Philippe Crespy, Laurent Journot, Frederic Hollande, Dominique Joubert

Proceedings of the National Academy of Sciences of the United States of America | NATL ACAD SCIENCES | Published : 2012

University of Melbourne Researchers

Grants

Awarded by Association pour la Recherche contre le Cancer


Funding Acknowledgements

We thank Robert. J. Lefkowitz (Duke University Medical Center) for Arrb1<SUP>-/-</SUP> and Arrb2<SUP>-/-</SUP> mice and rabbit polyclonal anti-beta-arrestin (A1CT); Anne Cohen-Solal and Denis Greuet for excellent help in animal care and breeding; Joanne Ryan for her help in statistical analyses; Paul White and Florence Cabon for excellent advice on in vivo siRNA bio-distribution; Chantal Ripoll for her help in cryocut tissue sections; and Philippe Jay, Catherine Legraverend, and Joel Bockaert for scientific discussions and for comments on the manuscript. This work was supported by Grant 4996 from the Association pour la Recherche contre le Cancer and by Groupements des Entreprises Francaises dans la Lutte contre le Cancer.